Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
27%
OVERLAP
BY WEIGHT
24
# OF OVERLAPPING
HOLDINGS
WDNA
85
HOLDINGS
30%
ALSO IN BBP
BBP
67
HOLDINGS
39%
ALSO IN WDNA
SECTOR DRIFT (WDNA minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
AMICUS THERAPEUTICS INC | 2.2% | 2.1% | 2.1% |
|
AMGEN INC | 2.2% | 1.6% | 1.6% |
|
GILEAD SCIENCES INC | 1.7% | 1.6% | 1.6% |
 |
BIONTECH SE SPONSORED ADR | 2.3% | 1.6% | 1.6% |
|
MODERNA, INC. | 2.6% | 1.6% | 1.6% |
WDNA Overweight Relative to BBP
|
ELI LILLY & CO | 3.1% |
|
NATERA INC | 2.9% |
|
JOHNSON & JOHNSON | 2.7% |
|
STOKE THERAPEUTICS, INC. | 2.5% |
|
PFIZER INC | 2.4% |
|
REGENXBIO, INC. | 2.3% |
 |
NOVO NORDISK A/S-B | 2.2% |
 |
ASTRAZENECA PLC-SPONS ADR | 2.1% |
|
BEAM THERAPEUTICS, INC. | 2.1% |
|
NOVOZYMES A/S-B SHARES | 2.0% |
WDNA Underweight Relative to BBP
|
DYNAVAX TECHNOLOGIES CORP | -2.2% |
|
AXSOME THERAPEUTICS, INC. | -1.9% |
|
MIRUM PHARMACEUTICALS, INC. | -1.9% |
|
PHATHOM PHARMACEUTICALS, INC. | -1.8% |
|
DAY ONE BIOPHARMACEUTICALS, INC. | -1.7% |
|
TRAVERE THERAPEUTICS, INC. | -1.7% |
|
NUVATION BIO INC CLASS A | -1.7% |
|
INCYTE CORP | -1.6% |
|
SYNDAX PHARMACEUTICALS INC | -1.6% |
|
BIOCRYST PHARMACEUTICALS INC | -1.6% |